台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效

生展

(8279)
  • 股價
    155.0
  • 漲跌
    ▲3.0
  • 漲幅
    +1.97%
  • 成交量
    10
  • 產業
    上櫃 生技醫療類股
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
生展 (8279)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/12 ~ 2024/04/26     後一日»

券商獲利排行 - 2024/04/12 ~ 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.14%6.506.5220151.8151.80155
  1.42%6.506.5330152.8152.80155
  1.31%660033153152154155
  0.15%5.524.5-1982315158157.4159155
  3.33%5051101501500155
  2.96%4.54.50011152.3150154.5155
  2.99%4.504.5110150.5150.50155
  2.65%4041101511510155
  1.65%2.52.50011151.3150152.5155
  1.31%2021101531530155
  0.32%101220154.5154.50155
   0000001530153155
   0000001550155155
   0000001541540155
   000000153.70153.7155
   0000001560156155
   0000001520152155
   0000001501500155
   0000001551550155
   0000001540154155
   0000001620162155
   0000001530153155
   000000152.5152153155
   0000001541540155
   0000001530153155
   0000001531530155
   0000001530153155
   000000157.9157.90155
   0000001510151155
   000000152.4152.40155
   0000001540154155
   0000001601600155
   000000153.5153.50155
   0000001511510155
   000000153.4153.40155
   0000001531530155
   0000001531530155
   0000001510151155
   0000001530153155
   0000001531530155
   0000001531530155
   000000154.8154.80155
   000000158.4153.5159155
   0000001591590155
   000000151.90151.9155
   0000001531530155
   000000152151153155
   0000001501500155
   0000001530153155
  -0.32%-0.50-0.5001154.5154154.5155

券商虧損排行 - 2024/04/12 ~ 2024/04/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -3.33%-150-15-3031500150155
  -1.97%-90-9-3031520152155
  -2.82%-8.50-8.5-202150.80150.8155
  -2.65%-40-4-1011510151155
  -0.81%-2.50-2.5-202153.80153.8155
  -1.31%-20-2001153153.1153155
  -1.31%-20-2-1011530153155
  -1.12%-1.7-1.70011153.6154.5152.8155
  -0.32%-10-1-202154.50154.5155
  -0.31%-10-1-202154.5151154.5155
  -0.32%-0.50-0.5-101154.50154.5155
  -0.32%-0.50-0.5001154.5154154.5155
   0000001530153155
   0000001531530155
   0000001531530155
   000000154.8154.80155
   0000001531530155
   000000152151153155
   0000001501500155
   0000001530153155
   000000158.4153.5159155
   0000001591590155
   000000151.90151.9155
   000000153.5153.50155
   0000001511510155
   0000001540154155
   0000001601600155
   0000001531530155
   0000001531530155
   0000001510151155
   000000153.4153.40155
   000000152.4152.40155
   0000001510151155
   0000001530153155
   0000001550155155
   0000001541540155
   000000153.70153.7155
   0000001560156155
   0000001520152155
   0000001501500155
   0000001551550155
   0000001540154155
   0000001620162155
   0000001530153155
   0000001531530155
   0000001530153155
   000000157.9157.90155
   0000001530153155
   000000152.5152153155
   0000001541540155
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章